Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1983 May;49(1):53–59.

Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.

T Skogh, O Stendahl
PMCID: PMC1454113  PMID: 6404812

Abstract

The effect of serum complement upon the blood clearance rate and tissue distribution of intravenously injected small immune complexes formed between 125-labelled dinitrophenyl (DNP)-conjugated human serum albumin and rabbit IgG-anti-DNP antibodies was studied in mice. Immune complexes formed in the absence of complement (i.e. in phosphate-buffered saline or in the presence of complement-depleted serum from mice treated with cobra venom factor) were cleared from the blood at a higher rate than was the antigen injected alone. In contrast, immune complexes formed in the presence of fresh normal mouse serum were cleared from the blood at the same rate as was the native antigen. Immune complexes formed in the presence of complement were eliminated mainly by the liver. The complexes formed in the absence of complement also became located to the liver to approximately the same extent, but an even larger proportion of these immune complexes was deposited outside the reticuloendothelial system. It is concluded that serum complement may inhibit IgG-mediated clearance of antigen, probably by increasing the solubility of the complexes, thereby reducing the risk of deposition outside the reticuloendothelial system.

Full text

PDF
53

Images in this article

56Figure 2
on p.56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguado M. T., Perrin L. H., Miescher P. A., Lambert P. H. Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus. Arthritis Rheum. 1981 Oct;24(10):1225–1229. doi: 10.1002/art.1780241001. [DOI] [PubMed] [Google Scholar]
  2. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arend W. P., Mannik M. In vitro adherence of soluble immune complexes to macrophages. J Exp Med. 1972 Sep 1;136(3):514–531. doi: 10.1084/jem.136.3.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arend W. P., Mannik M. Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol. 1971 Jul;107(1):63–75. [PubMed] [Google Scholar]
  5. Bockow B., Mannik M. Clearance and tissue uptake of immune complexes in complement-depleted and control mice. Immunology. 1981 Apr;42(4):497–504. [PMC free article] [PubMed] [Google Scholar]
  6. Brown D. L., Harkiss G. D. In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits. Clin Exp Immunol. 1981 Feb;43(2):231–239. [PMC free article] [PubMed] [Google Scholar]
  7. Brown D. L., Lachmann P. J., Dacie J. V. The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. Clin Exp Immunol. 1970 Sep;7(3):401–421. [PMC free article] [PubMed] [Google Scholar]
  8. Finbloom D. S., Abeles D., Rifai A., Plotz P. H. The specificity of uptake of model immune complexes and other protein aggregates by the murine reticuloendothelial system. J Immunol. 1980 Sep;125(3):1060–1065. [PubMed] [Google Scholar]
  9. Haakenstad A. O., Mannik M. Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol. 1974 May;112(5):1939–1948. [PubMed] [Google Scholar]
  10. Harkiss G. D., Brown D. L. Clearance kinetics of soluble pre-formed immune complexes containing IgM antibodies in normal and decomplemented rabbits. Immunology. 1981 Feb;42(2):297–306. [PMC free article] [PubMed] [Google Scholar]
  11. Hellsing K. Immune reactions in polysaccharide media. The effect of hyaluronate, chondroitin sulphate and chondroitin sulphate-protein complex on the precipitin reaction. Biochem J. 1969 May;112(4):475–481. doi: 10.1042/bj1120475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kijlstra A., van Es L. A., Daha M. R. Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement. Immunology. 1981 Jun;43(2):345–352. [PMC free article] [PubMed] [Google Scholar]
  13. Kijlstra A., van Es L. A., Daha M. R. The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages. J Immunol. 1979 Dec;123(6):2488–2493. [PubMed] [Google Scholar]
  14. Klaus G. G., Pepys M. B., Kitajima K., Askonas B. A. Activation of mouse complement by different classes of mouse antibody. Immunology. 1979 Dec;38(4):687–695. [PMC free article] [PubMed] [Google Scholar]
  15. Leslie R. G. The binding of soluble immune complexes of guinea pig IgG2 to homologous peritoneal macrophages. Determination of the avidity constants at 4 degrees C. Eur J Immunol. 1980 May;10(5):317–322. doi: 10.1002/eji.1830100502. [DOI] [PubMed] [Google Scholar]
  16. Marchalonis J. J. An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J. 1969 Jun;113(2):299–305. doi: 10.1042/bj1130299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miklós K., Kulics J., Franek F., Füst G., Gergely J. Complement-mediated fragmentation of soluble and insoluble immune complexes containing porcine anti-DNP antibodies. Mol Immunol. 1982 Feb;19(2):307–312. doi: 10.1016/0161-5890(82)90344-3. [DOI] [PubMed] [Google Scholar]
  18. Miller G. W., Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975 Feb;72(2):418–422. doi: 10.1073/pnas.72.2.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Møller N. P., Steensgaard J. Fc-mediated immune precipitation. II. Analysis of precipitating immune complexes by rate-zonal ultracentrifugation. Immunology. 1979 Nov;38(3):641–648. [PMC free article] [PubMed] [Google Scholar]
  20. NIH conference. Pathophysiology of immune hemolytic anemia. Ann Intern Med. 1977 Aug;87(2):210–222. doi: 10.7326/0003-4819-87-2-210. [DOI] [PubMed] [Google Scholar]
  21. Schifferli J. A., Morris S. M., Dash A., Peters D. K. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis. Clin Exp Immunol. 1981 Dec;46(3):557–564. [PMC free article] [PubMed] [Google Scholar]
  22. Schifferli J. A., Peters D. K. Complement-mediated inhibition of immune precipitation. II. Analysis by sucrose density gradient ultracentrifugation. Clin Exp Immunol. 1982 Mar;47(3):563–569. [PMC free article] [PubMed] [Google Scholar]
  23. Schifferli J. A., Woo P., Peters D. K. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol. 1982 Mar;47(3):555–562. [PMC free article] [PubMed] [Google Scholar]
  24. Schrieber L., Penny R. Tissue distribution of IgG Fc receptors. Clin Exp Immunol. 1982 Mar;47(3):535–540. [PMC free article] [PubMed] [Google Scholar]
  25. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  26. Skogh T., Hed J., Stendahl O. Complement-mediated inhibition of non-specific aggregation of highly-dinitrophenyl-conjugated human serum albumin. Immunol Commun. 1982;11(5):337–344. doi: 10.3109/08820138209050733. [DOI] [PubMed] [Google Scholar]
  27. Skogh T. Tissue distribution of intravenously injected dinitrophenylated human serum albumin. Effects of specific IgG and IgA antibodies. Scand J Immunol. 1982 Dec;16(6):465–475. doi: 10.1111/j.1365-3083.1982.tb00747.x. [DOI] [PubMed] [Google Scholar]
  28. Sliwinski A. J., Zvaifler N. J. Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus. Clin Exp Immunol. 1972 May;11(1):21–29. [PMC free article] [PubMed] [Google Scholar]
  29. Takahashi M., Takahashi S., Hirose S. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions. Prog Allergy. 1980;27:134–166. [PubMed] [Google Scholar]
  30. Teisberg P. Complement system studies in systemic lupus erythematosus (SLE) Acta Med Scand. 1975 Jan-Feb;197(1-2):131–134. doi: 10.1111/j.0954-6820.1975.tb04890.x. [DOI] [PubMed] [Google Scholar]
  31. van Snick J. L., Masson P. L. The effect of complement on the ingestion of soluble antigen-antibody complexes and IgM aggregates by mouse peritoneal macrophages. J Exp Med. 1978 Oct 1;148(4):903–914. doi: 10.1084/jem.148.4.903. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES